Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon D Roger
Ashraf Mikhail

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|August 31, 2007
Biosimilars: opportunity or cause for concern?Simon D Roger, Ashraf Mikhail
Journal of Blood Medicine|June 22, 2012
Profile of peginesatide and its potential for the treatment of anemia in adults with chronic kidney disease who are on dialysisAshraf Mikhail
Kidney & Blood Pressure Research|September 15, 2007
Biosimilars in clinical practiceAshraf Mikhail
The New England Journal of Medicine|December 14, 2007
Epoetin alfa in critically ill patientsAshraf Mikhail
Advances in Therapy|December 18, 2012
Epoetin biosimilars in Europe: five years onAshraf Mikhail, Mourad Farouk
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 9, 2006
European regulatory guidelines for biosimilarsAndrzej Wiecek, Ashraf Mikhail
The New England Journal of Medicine|March 6, 2007
Chronic kidney disease, anemia, and epoetinAshraf Mikhail, David Goldsmith
Nephrology (Carlton, Vic.)|August 8, 2006
Biosimilars: how similar or dissimilar are they?Simon D Roger
Nephrology (Carlton, Vic.)|October 4, 2006
Proton pump inhibitors: indigestion for nephrologists!Simon D Roger
The New England Journal of Medicine|March 6, 2007
Chronic kidney disease, anemia, and epoetinSimon D Roger
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|August 31, 2007
Biosimilars: opportunity or cause for concern?Simon D Roger, Ashraf Mikhail
Journal of Blood Medicine|June 22, 2012
Profile of peginesatide and its potential for the treatment of anemia in adults with chronic kidney disease who are on dialysisAshraf Mikhail
Kidney & Blood Pressure Research|September 15, 2007
Biosimilars in clinical practiceAshraf Mikhail
The New England Journal of Medicine|December 14, 2007
Epoetin alfa in critically ill patientsAshraf Mikhail
Advances in Therapy|December 18, 2012
Epoetin biosimilars in Europe: five years onAshraf Mikhail, Mourad Farouk
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 9, 2006
European regulatory guidelines for biosimilarsAndrzej Wiecek, Ashraf Mikhail
The New England Journal of Medicine|March 6, 2007
Chronic kidney disease, anemia, and epoetinAshraf Mikhail, David Goldsmith
Nephrology (Carlton, Vic.)|August 8, 2006
Biosimilars: how similar or dissimilar are they?Simon D Roger
Nephrology (Carlton, Vic.)|October 4, 2006
Proton pump inhibitors: indigestion for nephrologists!Simon D Roger
The New England Journal of Medicine|March 6, 2007
Chronic kidney disease, anemia, and epoetinSimon D Roger
Pageof 10